FASTINOV secures pre-Series A financing of €3.5 million

Explorer Investments and Quilaban supported further R&D, commercialization and international growth.

FASTINOV update

This update forms part of FASTINOV’s news and insights on clinical microbiology workflows, scientific work, events and technology development.

View original publication →